Effect of losartan irbesartan and candesartan on platelet aggregability and fibrinolysis in type 2 diabetic hypertensive patients

被引：0
|
作者：
Fogari, R
Derosa, G
Mugellini, A
Preti, P
Rinaldi, A
Pasotti, C
Malacco, E
Corradi, L
机构：
[1] Univ Pavia, Dept Internal Med, I-27100 Pavia, Italy
[2] Osped L Sacco, Dept Internal Med, Milan, Italy
来源：
AMERICAN JOURNAL OF HYPERTENSION | 2003年 / 16卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
P86
引用
收藏
页码：70A / 70A
页数：1
相关论文
共 50 条
  • [1] Effect of losartan irbesartan and candesartan on platelet aggregability and fibrinolysis in type 2 diabetic hypertensive patients
    Fogari, R
    Derosa, G
    Mugellini, A
    Preti, P
    Rinaldi, A
    Pasotti, C
    Malacco, E
    Corradi, L
    JOURNAL OF HYPERTENSION, 2003, 21 : S85 - S86
  • [2] The effects of losartan and fosinopril diabetic patients in hypertensive type 2
    Kavgaci, H
    Sahin, A
    Ersoz, O
    Erem, C
    Ozdemir, F
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2002, 58 (01) : 19 - 25
  • [3] THE EFFECT OF IRBESARTAN AND LOSARTAN ON BLOOD PRESSURE AND COGNITIVE FUNCTION IN HYPERTENSIVE PATIENTS
    Afanasyeva, N.
    Mordovin, V.
    JOURNAL OF HYPERTENSION, 2010, 28 : E553 - E553
  • [4] Effect of amlodipine vs candesartan on left ventricular hypertrophy in hypertensive type 2 diabetic patients
    Fogari, R
    Preti, P
    Malacco, E
    Corradi, L
    Pasotti, C
    Rinaldi, A
    Zoppi, A
    Mugellini, A
    AMERICAN JOURNAL OF HYPERTENSION, 2003, 16 (05) : 87A - 87A
  • [5] Effect of amlodipine vs candesartan on left ventricular hypertrophy in hypertensive type 2 diabetic patients
    Fogari, R
    Preti, P
    Malacco, E
    Corradi, L
    Pasotti, C
    Rinaldi, A
    Zoppi, A
    Mugellini, A
    JOURNAL OF HYPERTENSION, 2003, 21 : S85 - S85
  • [6] Effect of Pentoxifylline on inflammatory burden, oxidative stress and platelet aggregability in hypertensive type 2 diabetes mellitus patients
    Maiti, Rituparna
    Agrawal, N. K.
    Dash, D.
    Pandey, B. L.
    VASCULAR PHARMACOLOGY, 2007, 47 (2-3) : 118 - 124
  • [7] Effect of Aliskiren Addition to Losartan on Fibrinolysis in Diabetic Hypertensive Patients: A Three-Way Crossover Study
    Fogari, Roberto
    Mugellini, Amedeo
    Preti, Paola
    Perrone, Tiziano
    Maffioli, Pamela
    Derosa, Giuseppe
    DIABETES, 2012, 61 : A619 - A619
  • [8] Effect of delapril-manidipine combination versus irbesartan-hydrochlorothiazide combination on fibrinolysis in hypertensive diabetic patients
    Fogari, R
    Mugellni, A
    Zoppi, A
    Derosa, G
    Rinaldi, A
    Preti, P
    EUROPEAN HEART JOURNAL, 2002, 23 : 114 - 114
  • [9] Differential effect of candesartan and olmesartan on adipose tissue activity biomarkers in type 2 diabetic hypertensive patients
    Derosa, G.
    Maffioli, P.
    Salvadeo, S. A. T.
    Ferrari, I.
    Gravina, A.
    Mereu, R.
    Palumbo, I.
    Randazzo, S.
    Fogari, E.
    Angelo, A.
    EUROPEAN HEART JOURNAL, 2010, 31 : 532 - 532
  • [10] Effect of amlodipine versus candesartan on left-ventricular hypertrophy in hypertensive type 2 diabetic patients
    Fogari, R
    Preti, P
    Banderali, A
    Corradi, L
    Rinaldi, A
    Zoppi, A
    Malacco, E
    Mugellini, A
    EUROPEAN HEART JOURNAL, 2003, 24 : 663 - 663
12345